Mycronic AB (0MQG)
London Exchange · UK · prices in SEK · close of 15 Oct 2026
Key indicators
| Last close | SEK 306.40 |
|---|---|
| 52-week range | 183.86 – 363.80 |
| Return, 1 month / 3 months | −2.4% / −9.7% |
| Return, 1 year / 3 years | +39.0% / +190.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 35 |
| Volatility (1 year) | 38.6% |
| Worst drawdown (1 year) | -17.4% |
| Average daily value traded | 10.66M SEK |
| Dividend yield | 1.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mycronic AB is a Swedish company that develops and supplies production equipment for the electronics and display industries. Its product areas include surface mount technology assembly equipment, dispensing and jetting systems, and mask writers used to produce photomasks for displays and semiconductors. Customers are manufacturers and suppliers in electronics assembly, display production and semiconductor fabrication, and the company is based in Taby, Sweden, with operations in several countries.
Mycronic AB trades under the code 0MQG on the London Exchange in UK, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mycronic AB (0MQG) trades on the London Exchange in UK. It last closed at SEK 306.40 on 15 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 856 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 39.0% and over the last three months it fell 9.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 11.7% | ||
| From 52-week high | -14.9% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -9.7% | ||
| 6-month return | 22.7% | ||
| 12-month return, skipping the last month | 42.4% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 38.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.4% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 10.66M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 44 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.1% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −11.3% |
|---|---|
| 1 month | −2.4% |
| 3 months | −9.7% |
| 6 months | +22.7% |
| 1 year | +39.0% |
| 3 years | +190.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 327.37 / 274.36 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 10.21 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 May 2026 | SEK 3.2500 |
| 8 May 2025 | SEK 5.5000 |
| 10 May 2024 | SEK 4.5000 |
| 10 May 2023 | SEK 3.5000 |
| 6 May 2022 | SEK 3.0000 |
| 6 May 2021 | SEK 3.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.